Further experiments should use in vitro tests to explore the exact mechanisms underlying the interactions of IL-23 and IL-27 with other cells, cytokines, and genes known to be susceptible to the development of GBS. This evidence concerns the gene IL27 and Guillain-Barre syndrome.